Daniel Sjöborn

Daniel Schulz-Jander is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Sr. Director at QPS Netherlands B.V. since February 2022, Daniel previously held significant roles including Site & Lab Head for Bioanalytical and Biologics Services at Frontage Laboratories, and Distinguished Scientist at Medtronic, where strategic leadership was provided for the development and regulatory approval of drug combination products. With a solid educational foundation that includes a Ph.D. in Analytical Chemistry from the Technical University of Munich and a Postdoctoral Research degree in Small Molecule Metabolism from the University of California, Berkeley, Daniel's expertise spans analytical chemistry development, regulatory compliance, and the characterization of drug products from concept to commercialization.